Phibro Animal Health | PAHC - Interest Expense On Debt


Phibro Animal Health reported $11.91M in Interest Expense on Debt for its fiscal quarter ending in December of 2025.





Interest Expense On Debt Change Date
Align Technology USD 2M 660K Mar/2023
ANI Pharmaceuticals USD 4.41M 316K Dec/2025
Assertio Holdings USD 758K 1000 Jun/2024
Aurora Cannabis CAD 2.11M 116K Dec/2025
Bristol-Myers Squibb USD 432M 48M Dec/2025
Canopy Growth CAD 7.34M 1.46M Dec/2025
Corcept Therapeutics USD 823.61M 21.88M Sep/2025
Eli Lilly USD 114.7M 134.3M Sep/2025
Henry Schein USD 39M 1000K Dec/2025
Idexx Laboratories USD 10.08M 1.24M Sep/2025
Knight Therapeutics CAD 3.92M 1.56M Dec/2025
Merck USD 412M 85M Dec/2025
Nektar Therapeutics USD 6.02M 420K Sep/2024
Pacira USD 3.89M 387K Dec/2025
Phibro Animal Health USD 11.91M 191K Dec/2025
Prestige Brands USD 10.67M 636K Dec/2025
Supernus Pharmaceuticals USD 910K 278K Jun/2023
Zoetis USD 57M 1000K Dec/2025